Journals / Eurasian Journal of Pulmonology / 2019 / Cilt: 21 - Sayı: 3

Chronic obstructive pulmonary disease phenotypes: Are they really useful in clinical practice?

Pages
143–147
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article is to review predefined COPD phenotypes, their clinical andepidemiological features, and usefulness in clinical practice for accurate diagnosis and appropriatetreatment of COPD patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortalityworldwide.
📊
Key Findings & Data:In recent years, studies showed that forcedexpiratory volume in 1 s solely was not enough to describe heterogeneity of COPD patients, andsubsequently, phenotypes of COPD were identified.
💡
Conclusion & Impact:The aim of this article is to review predefined COPD phenotypes, their clinical andepidemiological features, and usefulness in clinical practice for accurate diagnosis and appropriatetreatment of COPD patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortalityworldwide. It is a complex and heterogeneous disease. In recent years, studies showed that forcedexpiratory volume in 1 s solely was not enough to describe heterogeneity of COPD patients, andsubsequently, phenotypes of COPD were identified. The aim of phenotyping is the classificationof patients into distinct subgroups according to the prognosis and response to therapy so that theselection of optimal therapy can be possible, and this clinical approach may improve prognosis.In the assessment and management of the disease, it is important to consider phenotype of aCOPD patient. The aim of this article is to review predefined COPD phenotypes, their clinical andepidemiological features, and usefulness in clinical practice for accurate diagnosis and appropriatetreatment of COPD patients.

🔖

Cite This Article

AKPINAR, E. E., HOŞGÜN, D. (2022). Chronic obstructive pulmonary disease phenotypes: Are they really useful in clinical practice?. Eurasian Journal of Pulmonology, Cilt: 21 - Sayı: 3, 143–147. https://ajindex.com/articles/509647

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM, et al. Global burden of COPD: Systematic review and meta‑analysis. Eur Respir J 2006;28:523‑32
  2. Snider GL, Kleinerman J. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985;132:182‑5
  3. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122
  4. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med 2010;182:598‑604
  5. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and prevention of Chronic Obstructive Pulmonary Disease; 2019. Available from: http://www.goldcopdorg/. [Last accessed on 2018 Dec 03]
  6. Miravitlles M, Soler‑Cataluña JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: Putting old evidence into clinical practice. Eur Respir J 2013;41:1252‑6
  7. Miravitlles M, Soler‑Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol 2017;53:324‑35
  8. O’Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M; Guideline Development Group, et al. Management of stable chronic obstructive pulmonary disease in primary and secondary care: Summary of updated NICE guidance. BMJ 2010;340:c3134
  9. Han MK, Quibrera PM, Carretta EE, Barr RG, Bleecker ER, Bowler RP, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: An analysis of the SPIROMICS cohort. Lancet Respir Med 2017;5:619‑26
  10. Ciba Foundation Guest Symposium. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. Thorax 1959;14:286‑99
  11. American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema: A statement by the committee on diagnostic standarts for nontuberculous respiratıry diseases. Am Rev Respir Dis 1962;85:762‑8
  12. World Health Organization. Chronic cor pulmonale. Report of an expert committee World Health Organ Tech Rep Ser 1961;213:35
  13. Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:228‑37
  14. Diagnosis of Diseases of Chronic A